Comparison of Sodium Hypochlorite Gel and Solution With and Without Nanoparticles for Postoperative Pain After Pulpotomy in Permanent Mandibular Molars

Comparative Evaluation of Sodium Hypochlorite Gel and Solution, With and Without Nano-particles, on Post-operative Pain Following Pulpotomy in Permanent Mandibular Molar Teeth; "Randomized Clinical Trail"

This randomized clinical trial aims to compare the effect of 2% sodium hypochlorite gel and solution, with and without chitosan nanoparticles, on postoperative pain following pulpotomy in mature permanent mandibular molars with symptomatic irreversible pulpitis. Participants will be randomly allocated into four parallel groups receiving either 2% sodium hypochlorite solution, 2% sodium hypochlorite gel, 2% sodium hypochlorite solution containing chitosan nanoparticles, or 2% sodium hypochlorite gel containing chitosan nanoparticles as the haemostatic agent during pulpotomy. Postoperative pain will be assessed using an 11-point Numerical Rating Scale at 6, 12, 24, and 72 hours and 7 days after treatment. The study will also evaluate the overall clinical and radiographic success of pulpotomy during follow-up.

Inclusion Criteria:

• • Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars.

  • Patients of either gender aged from 15-40.
  • Patients free from any systemic disease that may affect normal healing and predictable outcome.
  • Patients who will agree to the consent and will commit to follow-up period.
  • Patients with mature root.
  • Patients with no internal or external resorption and no periapical lesions.
  • Tooth give positive response to sensitivity test.
  • Tooth is restorable and free from advanced periodontal disease, cracks and splits.
  • Hemostasis achieved after total pulpotomy.
  • Soft tissues around the tooth are normal with no swelling or sinus tract.

Exclusion Criteria:

• • Hemostasis after 10 minutes can not be controlled after total pulpotomy.

  • Patients with immature roots.
  • Patients with any systemic disease that may affect normal healing.
  • Patients with periapical lesions or infections.
  • Pregnant females.
  • Patients who could/would not participate in a 6 months follow-up.
  • Patients with fistula or swelling
  • Patients with necrotic pulp.
  • Patients with old age.